Xu Xiaoyan

机构：Shenyang Medical College, China Medical University · ORCID：0000-0002-6812-8129

发表论文 8 篇 · 总被引 492 次 · h-index 5

代表论文

• Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers (2018 · Cell Reports · 被引 395)
• A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer (2022 · Cell Death and Disease · 被引 44)
• Metabolism in Cancer Stem Cells: Targets for Clinical Treatment (2022 · Cells · 被引 21)
• EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: R esponse to apatinib and clinical outcomes (2018 · Thoracic Cancer · 被引 17)
• Roles of ROS/TACE in neutrophil elastase-induced mucus hypersecretion in NCI-H292 airway epithelial cells. (2010 · PubMed · 被引 14)
• Use of tumor suppressor genes of naked mole rats for human cancer treatment. (2023 · PubMed)